Heron Therapeutics HRTX Q2 2025 earnings
Reported August 8, 2025 · After market close
Revenue$37.2MMiss by $1.9M
EPS-$0.02Miss by $0.01
Revenue estimate$39.1M
EPS estimate-$0.01
Next report
Aug 10, 2026 (In 1 week)Revenue estimate$42.2M
EPS estimate-$0.02
Versus estimates
Revenue
Diluted EPS
Ask the moment Heron Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Heron Therapeutics report Q2 2025 earnings?
- Heron Therapeutics (HRTX) reported Q2 2025 earnings on August 8, 2025 after market close.
- What were Heron Therapeutics's Q2 2025 revenue and EPS?
- Heron Therapeutics reported revenue of $37.2M and eps of $-0.02 for Q2 2025.
- Did Heron Therapeutics beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $39.1M by $1.9M. EPS missed the consensus estimate of $-0.01 by $0.01.
- How did Heron Therapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 3.3% from $36.0M a year earlier and eps grew 66.7% from $-0.06.
- Where can I find Heron Therapeutics's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-105475) directly on SEC EDGAR. The filing index links above go to sec.gov.